Discover 1,424 paid clinical trials in Clearwater, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,424
Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma
for
Melanoma Stage III, Melanoma Stage IV, BRAF V600 Mutation
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT04741997
Early Phase 1, Recruiting
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
for
Cutaneous Melanoma, Stage II
Location: Tampa FL, Lakeland FL, Jacksonville FL,
Sponsor: Melanoma and Skin Cancer Trials Limited
Sex: All
Age: 18+
Code: NCT03860883
Recruiting
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML/HR-MDS and in Combination With Azacitidine in Previously Untreated HR-MDS
for
AML, Adult, MDS
Location: Tampa FL, Houston TX, Columbus OH, St Louis MO,
Sponsor: Stelexis BioSciences
Sex: All
Age: 18+
Code: NCT06533761
Phase 1, Recruiting
Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma
for
Myeloma
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT06947083
Phase 2, Recruiting
Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue Sarcoma
for
High Grade Sarcoma
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT05301283
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors
for
Advanced or Metastatic Solid Tumors
Location: Tampa FL, Cincinnati OH, San Antonio TX,
Sponsor: Hanmi Pharmaceutical Company Limited
Sex: All
Age: 18+
Code: NCT06234397
Phase 1, Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
for
cGVHD
Location: Orlando FL, Jacksonville FL, Augusta GA, Atlanta GA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT05919511
Recruiting
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
for
Oncology, MEK Mutation, RAF Gene Mutation,
Location: Tampa FL, Nashville TN, Denver CO, Houston TX,
Sponsor: Nested Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06326411
Phase 1, Recruiting
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
for
Chronic Graft-Versus-Host Disease (cGVHD)
Location: Tampa FL, Orlando FL, Atlanta GA, Charlotte NC,
Sponsor: Deciphera Pharmaceuticals, LLC
Sex: All
Age: 18+
Code: NCT06619561
Phase 2, Recruiting
Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma
for
Advanced Basal Cell Carcinoma
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT05651828
Early Phase 1, Recruiting
Abatacept in Immune Checkpoint Inhibitor Myocarditis
for
Myocarditis Acute, Cancer
Location: Tampa FL, Chapel Hill NC, Lexington KY, Morgantown WV,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT05335928
Phase 3, Recruiting
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
for
Cardiotoxicity, HER2/Neu Positive,
Location: Tampa FL, Weston FL, Thomasville GA, Savannah GA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT03418961
Phase 3, Recruiting
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
for
Relapsed and/or Refractory Multiple Myeloma
Location: Tampa FL, Birmingham AL, Nashville TN, New York NY,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06153251
Phase 1, Recruiting
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
for
Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer,
Location: Tampa FL, Sarasota FL, Nashville TN, Houston TX,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06128551
Phase 1, Phase 2, Recruiting
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
for
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Tampa FL, Richmond VA, Cincinnati OH, West Chester OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05172245
Phase 1, Recruiting
QTX3034 in Patients With KRAS G12D Mutation
for
Solid Tumors
Location: Tampa FL, Sarasota FL, Durham NC, Nashville TN,
Sponsor: Quanta Therapeutics
Sex: All
Age: 18+
Code: NCT06227377
Phase 1, Recruiting
A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
for
Peritoneal Carcinomatosis, Ovarian Cancer
Location: Tampa FL
Sponsor: Oncoinvent Solutions AS
Sex: Female
Age: 18+
Code: NCT06504147
Phase 2, Recruiting
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
for
Advanced Breast Cancer
Location: Tampa FL, Sarasota FL, Orlando FL, Altamonte Springs FL,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06638307
Phase 1, Recruiting
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Tampa FL, Atlanta GA, Chattanooga TN, Baton Rouge LA,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT05379985
Phase 1, Phase 2, Recruiting
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry